Aguiar Júnior P, Barreto CMN, Roitberg F, Lopes Júnior G, del Giglio A. Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study. Sao Paulo Med J [Internet]. 2019 Dec. 5 [cited 2025 Oct. 17];137(6):505-11. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/999